Evaluation of Treatment Satisfaction in Children With an Allergy and Who Received an Antihistamine
Information source: UCB
Information obtained from ClinicalTrials.gov on December 31, 2007
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Allergies
Intervention: All antihistamines available on the market (Drug)
Phase: N/A
Status: Not yet recruiting
Sponsored by: UCB Official(s) and/or principal investigator(s):
Marie-Etienne Pinelli, MD, Study Director, Affiliation: UCB
Overall contact:
UCB Clinical Trial Call Center, Phone: +1 877 822 9493
Summary
This is a non-interventional retrospective data collection study from children aged from 2 to
12 years old diagnosed with an allergy and who received a treatment consisting of an
H1-antihistamine. The period of last taken medication will be observed to evaluate the global
satisfaction of the parents and physician for this last treatment.
Clinical Details
Official title: Evaluation of the Treatment Satisfaction in Children Suffering From an Allergy and Who Received an Antihistamine Treatment
Study design: Natural History, Longitudinal, Defined Population, Retrospective Study
Eligibility
Minimum age: 2 Years.
Maximum age: 12 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
Children from 2-12 included
History of allergy
Used an Antihistamine within market authorization
Exclusion Criteria:
Child not yet treated for the presented allergy
Locations and Contacts
UCB Clinical Trial Call Center, Phone: +1 877 822 9493 Additional Information
Starting date: August 2007
Last updated: July 10, 2007
|
